* . * . * .

Eli Lilly ramps up its fight against imitation weight-loss drugs


The maker of blockbuster appetite-suppressing drugs Mounjaro and Zepbound is seeking to end a regulatory designation that has allowed cheaper, off-brand versions to flourish.




Source
Exit mobile version

.. . . . . . . . . . . . . . . . . . . . . . . . . %%%. . . * . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ - - - - - - - - - - - - - - - - - - - - . . . . .